Two Sigma Investments, LP Biogen Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Biogen Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 648,702 shares of BIIB stock, worth $102 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

648,702

Previous 212,899 204.7%

Holding current value

$102 Million

Previous $49.4 Million 154.78%

% of portfolio

0.3%

Previous 0.12%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $82.4 Million - $103 Million	435,803 Added 204.7%	648,702 $126 Million
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $21.6 Million - $26.9 Million	-113,526 Reduced 34.78%	212,899 $49.4 Million
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $57.8 Million - $72.9 Million	272,400 Added 504.21%	326,425 $70.4 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $7.68 Million - $9.25 Million	34,511 Added 176.85%	54,025 $14 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $1.43 Million - $1.62 Million	-5,652 Reduced 22.46%	19,514 $5.02 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $6.93 Million - $8 Million	25,166 New	25,166 $7.17 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $15.9 Million - $19.4 Million	63,121 Added 41.85%	213,939 $59.2 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $18.3 Million - $25.2 Million	-93,962 Reduced 38.39%	150,818 $40.3 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $78.5 Million - $93.4 Million	-418,752 Reduced 63.11%	244,780 $49.9 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $36 Million - $45.4 Million	185,871 Added 38.91%	663,532 $140 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $75.7 Million - $97.3 Million	338,031 Added 242.09%	477,661 $115 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $33 Million - $43 Million	116,441 Added 502.14%	139,630 $39.5 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $4.4 Million - $7.05 Million	17,000 Added 274.68%	23,189 $8.03 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $5.13 Million - $6.01 Million	-21,111 Reduced 77.33%	6,189 $1.73 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $5.91 Million - $7.5 Million	-21,981 Reduced 44.6%	27,300 $8.64 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $35.7 Million - $40.1 Million	-164,359 Reduced 76.93%	49,281 $11.5 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $36.6 Million - $40.4 Million	167,063 Added 358.68%	213,640 $50 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $9.75 Million - $15.2 Million	-44,989 Reduced 49.13%	46,577 $11 Million
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $14 Million - $17.8 Million	50,386 Added 122.36%	91,566 $27.6 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $12.1 Million - $15.8 Million	41,180 New	41,180 $14.5 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $244,128 - $290,950	-948 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $344,672 - $487,480	-1,325 Reduced 58.29%	948 $260,000
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $174,431 - $195,376	-567 Reduced 19.96%	2,273 $724,000
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $798,465 - $936,319	2,840	2,840 $889,000

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Biogen Inc. Transaction History